José Carballido
Company: Novartis
Job title: Executive Director – Translational Medicine & Preclinical Safety
Seminars:
Panel Discussion: Future Directions in Tolerizing Therapies 3:30 pm
• Creating a convincing preclinical data package to ignite regulatory excitement and push more ASIT therapies toward the clinic • Strategies for determining clinical endpoints by phase of development – are surrogate endpoints the way forward? • Assessing optimal modalities and disease areas for future development – are cell therapies the future of ASIT? Will…Read more
day: Custom Day Two
Chair’s Closing Remarks 4:00 pm
day: Custom Day Two
Chair’s Opening Remarks 8:20 am
day: Custom Day Two
Chair’s Opening Remarks 7:50 am
day: Conference Day One
Chair’s Closing Remarks 4:30 pm
day: Conference Day One